Abstract
A number of 2'- and 3'-modified thymidine 5'-O-monophosphate analogues were synthesized as potential leads for new anti-mycobacterial drugs. Evaluation of their affinity for Mycobacterium tuberculosis thymidine monophosphate kinase showed that a 2'-halogeno substituent and a 3'-azido function are the most favorable leads for further development of potent inhibitors of this enzyme.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antitubercular Agents / chemical synthesis*
-
Antitubercular Agents / pharmacology*
-
Crystallography, X-Ray
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / pharmacology*
-
Kinetics
-
Models, Molecular
-
Mycobacterium tuberculosis / drug effects
-
Mycobacterium tuberculosis / enzymology*
-
Nucleoside-Phosphate Kinase / antagonists & inhibitors*
-
Thymidine Monophosphate / analogs & derivatives*
-
Thymidine Monophosphate / chemical synthesis*
-
Thymidine Monophosphate / chemistry
Substances
-
Antitubercular Agents
-
Enzyme Inhibitors
-
Thymidine Monophosphate
-
Nucleoside-Phosphate Kinase
-
dTMP kinase